TABLE 1.

Clinical course, serology, and viremia of the patients analyzed

Patient no.	Anti-HCV core IgM index valuea			HCV RNAb		Genotypec	ALT leveld	Histological resulte	Follow-up (mo)
	T0	T1	T2	T1	T2
1	49	Neg	Neg	Neg	Neg		4	RC	9
2	18.7	Neg	21.9	Neg	Neg		1	NT	5
3	61.2	Neg	Neg	Neg	Neg		1	NT	1
4	50.5	16.4	21.5	Pos	Pos	1b	2	MoCH	21
5	58.3	Neg	Neg	Pos	Pos	1b	3	RC	16
6	160.6	73.9	60.3	Pos	Pos	NT	2	Cirrhosis	12f
7	152.9	111.5	253.3	Pos	Pos	1b	3	MiCH	21
8	62.8	19.3	132.2	Neg	Pos	1b	4	MiCH	39
9	181.3	57.1	22.8	Pos	Pos	1b	50	RC	0.5g
10	Neg	Neg	48.8	Neg	Pos	1a	1	NT	6
11	36.4	Neg	119.7	Neg	Pos	1b	1	NT	7
12	224.5	70	253.3	Pos	Pos	3a	1	MiCH	36
13	253.3	148.8	181.3	Neg	Neg		4	RC	1
14	60.3	Neg	66.7	Neg	Pos	1b	2	AH	3g
15	218.9	195	253.3	Pos	Pos	2a/2c	1	MoCH	13
16	142.7	24.6	253.3	Neg	Pos	ND	1	MoCH	36
17	158.1	16.9	253.3	Neg	Pos	1b	5	AH	15
18	113.5	23.7	160.6	Neg	Pos	1b	1	MiCH	13

^aNeg, negative. 

^bPos, positive. 

^cNT, not tested; ND, not determined. 

^dExpressed as a multiple of the normal range (<45 U/dl). 

^eRC, rejection crisis; MoCH, moderate chronic hepatitis; MiCH, mild chronic hepatitis; AH, acute hepatitis. 

^fHBsAg positive. 

^gDeath.